A Collaborative Epidemiological Investigation into the Criminal Fake Artesunate Trade in South East Asia
Background:
Since 1998 the serious public health problem in South East Asia of counterfeit artesunate, containing no or subtherapeutic amounts of the active antimalarial ingredient, has led to deaths from untreated malaria, reduced confidence in this vital drug, large economic losses for the legitimate manufacturers, and concerns that artemisinin resistance might be engendered.
Methods and Findings:
With evidence of a deteriorating situation, a group of police, criminal analysts, chemists, palynologists, and health workers collaborated to determine the source of these counterfeits under the auspices of the International Criminal Police Organization (INTERPOL) and the Western Pacific World Health Organization Regional Office. A total of 391 samples of genuine and counterfeit artesunate collected in Vietnam (75), Cambodia (48), Lao PDR (115), Myanmar (Burma) (137) and the Thai/Myanmar border (16), were available for analysis. Sixteen different fake hologram types were identified. High-performance liquid chromatography and/or mass spectrometry confirmed that all specimens thought to be counterfeit (195/391, 49.9%) on the basis of packaging contained no or small quantities of artesunate (up to 12 mg per tablet as opposed to ∼ 50 mg per genuine tablet). Chemical analysis demonstrated a wide diversity of wrong active ingredients, including banned pharmaceuticals, such as metamizole, and safrole, a carcinogen, and raw material for manufacture of methylenedioxymethamphetamine (‘ecstasy'). Evidence from chemical, mineralogical, biological, and packaging analysis suggested that at least some of the counterfeits were manufactured in southeast People's Republic of China. This evidence prompted the Chinese Government to act quickly against the criminal traders with arrests and seizures.
Conclusions:
An international multi-disciplinary group obtained evidence that some of the counterfeit artesunate was manufactured in China, and this prompted a criminal investigation. International cross-disciplinary collaborations may be appropriate in the investigation of other serious counterfeit medicine public health problems elsewhere, but strengthening of international collaborations and forensic and drug regulatory authority capacity will be required.
Vyšlo v časopise:
A Collaborative Epidemiological Investigation into the Criminal Fake Artesunate Trade in South East Asia. PLoS Med 5(2): e32. doi:10.1371/journal.pmed.0050032
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.0050032
Souhrn
Background:
Since 1998 the serious public health problem in South East Asia of counterfeit artesunate, containing no or subtherapeutic amounts of the active antimalarial ingredient, has led to deaths from untreated malaria, reduced confidence in this vital drug, large economic losses for the legitimate manufacturers, and concerns that artemisinin resistance might be engendered.
Methods and Findings:
With evidence of a deteriorating situation, a group of police, criminal analysts, chemists, palynologists, and health workers collaborated to determine the source of these counterfeits under the auspices of the International Criminal Police Organization (INTERPOL) and the Western Pacific World Health Organization Regional Office. A total of 391 samples of genuine and counterfeit artesunate collected in Vietnam (75), Cambodia (48), Lao PDR (115), Myanmar (Burma) (137) and the Thai/Myanmar border (16), were available for analysis. Sixteen different fake hologram types were identified. High-performance liquid chromatography and/or mass spectrometry confirmed that all specimens thought to be counterfeit (195/391, 49.9%) on the basis of packaging contained no or small quantities of artesunate (up to 12 mg per tablet as opposed to ∼ 50 mg per genuine tablet). Chemical analysis demonstrated a wide diversity of wrong active ingredients, including banned pharmaceuticals, such as metamizole, and safrole, a carcinogen, and raw material for manufacture of methylenedioxymethamphetamine (‘ecstasy'). Evidence from chemical, mineralogical, biological, and packaging analysis suggested that at least some of the counterfeits were manufactured in southeast People's Republic of China. This evidence prompted the Chinese Government to act quickly against the criminal traders with arrests and seizures.
Conclusions:
An international multi-disciplinary group obtained evidence that some of the counterfeit artesunate was manufactured in China, and this prompted a criminal investigation. International cross-disciplinary collaborations may be appropriate in the investigation of other serious counterfeit medicine public health problems elsewhere, but strengthening of international collaborations and forensic and drug regulatory authority capacity will be required.
Zdroje
1. World Health Organisation
2006
World Malaria Report – 2005
Available: http://www.rbm.who.int/wmr2005/html/1–2.htm. Accessed 22 July 2007.
2. Anon
2007
Malaria. World Health Organisation Media Centre
Available: http://www.who.int/mediacentre/factsheets/fs094/en/index.html. Accessed 10 August 2007.
3. ArrowKJPanosianCBGelbandH
2004
Saving lives, buying time: economics of malaria drugs in an age of resistance
Washington (DC)
Institute of Medicine of the National Academies
Available: http://www.nap.edu/books/0309092183/html/. Accessed 5 August 2007.
4. NewtonPNGreenMDFernándezFMDayNJPWhiteNJ
2006
Counterfeit anti-infective medicines.
Lancet Infect Dis
6
602
613
5. World Health Organisation
2006
WHO guidelines for the treatment of malaria
Geneva
WHO
Available: www.who.int/malaria/docs/TreatmentGuidelines2006.pdf. Accessed 26 January 2006.
6. Anon.
Table recording ACT producers – Artepal Project
Available: http://www.artepal.org/index.php?option=com_docman&task=doc_download&gid=13&Itemid=60. Accessed 5 August 2007.
7. RozendaalJ
2000
Fake antimalarials circulating in Cambodia.
Bull Mekong Malaria Forum
7
62
68
8. NewtonPNProuxSGreenMSmithuisFRozendaalJ
2001
Fake artesunate in southeast Asia.
Lancet
357
1948
1950
9. NewtonPNDondorpAMGreenMMayxayMWhiteNJ
2003
Counterfeit artesunate antimalarials.
Lancet
362
169
10. NewtonPNMcGreadyRFernándezFGreenMDSunjioM
2006
Manslaughter by fake artesunate in Asia—will Africa be next.
PLoS Medicine
3
e197
doi:10.1371/journal.pmed.0030197
11. DondorpAMNewtonPNMayxayMVan DammeWSmithuisFM
2004
Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials.
Trop Med Int Hlth
9
1241
1246
12. LonCTTsuyuokaRPhanouvongSNivannaNSocheatC
2006
Counterfeit and substandard antimalarial drugs in Cambodia.
Trans R Soc Trop Med Hyg
100
1019
1024
13. HallKANewtonPNGreenMDDe VeijMVandenaabeleP
2006
Characterization of counterfeit artesunate antimalarial tablets from southeast Asia.
Am J Trop Med Hyg
75
804
811
14. USP
2004
Fake antimalarials found in Yunnan Province, China, 2004
Available: http://www.usp.org/pdf/EN/dqi/yunnanTesting.pdf. Accessed 2 September 2007.
15. OyeniranM
NAFDAC seizes N3M malaria drugs. Nigeria Tribune 2006 Sept 28
Available: http://www.tribune.com.ng/28092006/news/news13.html. Accessed 3 November 2006.
16. AtemnkengMADe CockKPlaizier-VercammenJ
2007
Quality control of active ingredients in artemisinin derivative antimalarials within Kenya and DR Congo.
Trop Med Int Hlth
12
68
74
17. [No authors listed]
2007
Malaria drugs recalled in Kenya
Available: http://news.bbc.co.uk/1/hi/world/africa/6951586.stm. Accessed 20 August 2007.
18. HaysSIGuerraCATatemAJNoorAMSnowRW
2004
The global distribution and population at risk of malaria: past, present, and future.
Lancet Infect Dis
4
327
336
19. World Health Organisation Regional Office for the Western Pacific
2005
Dealers in death. Video documentary.
A film by Harrikrisna Anenden
A WHO production
Manila
Available: http://www.wpro.who.int/sites/mvp/documents/dealersindeath.htm. Accessed 2 September 2007.
20. GreenMDDwightLMWirtzRAWhiteNJ
2000
A colorimetric field method to assess the authenticity of drugs sold as the antimalarial artesunate.
J Pharm Biomed Anal
24
65
70
21. FernándezFMCodyRBGreenMDHamptonCYMcGreadyR
2006
Characterization of solid counterfeit drug samples by desorption electrospray ionization and direct-analysis-in-real-time coupled to time-of-flight mass spectrometry.
ChemMedChem
1
702
705
22. NyadongLGreenMDDe JesusVRNewtonPNFernándezFM
2007
Reactive desorption electrospray ionization linear ion trap mass spectrometry of latest-generation counterfeit antimalarials via noncovalent complex formation.
Anal Chem
79
2150
2157
23. RicciCNyadongLFernándezFMNewtonPNKazarianSG
2007
Combined fourier transform infrared imaging and desorption electrospray ionization linear ion trap mass spectrometry for the analysis of counterfeit antimalarial tablets.
Anal Bioanalytic Chem
387
551
559
24. de VeijMVandenabeelePHallKAFernándezFMGreenMD
2007
Fast detection and identification of counterfeit antimalarial tablets by Raman spectroscopy.
J Raman Spectrosc
38
181
187
25. GreenMDNetteyHVillalva-RojasOPamanivangCKhounsaknalathL
2007
Use of refractometry and colorimetry as field methods to rapidly assess antimalarial drug quality.
J Pharm Biomed Anal
43
105
110
26. McCreaJM
1950
On the isotopic chemistry of carbonates and palaeo-temperature scale.
J Chem Physics
18
849
857
27. HoefsJ
1996
Stable isotope geochemistry, 4th edition
New York
Springer-Verlag
201
28. HuangTC
1972
Pollen flora of Taiwan
Tapei
Ching-Hwa Press Co. Ltd
222
29. HuangTC
1981
Spore flora of Taiwan
Taipei
Tah-Jinn Press Co. Ltd
111
30. WangFSChienHFZhangYLYangHQ
1995
Pollen flora of China, 2nd edition
Beijing
Institute of Botany, Academia Sinica
461
31. BulalacaoLJ
1997
Pollen flora of the Philippines volume 1
Taguig Metro Manila
Department of Science and Technology
266
32. YeSTQiaoBSWangLGYinJNiuZP
2004
Color atlas of air-borne pollens and plants in China
Beijing
Peking Union Medical College Press
385
33. HeywoodVH
1978
Flowering plants of the world
Oxford
Oxford University Press
335
34. United Nations
1988
United Nations convention against illicit traffic in narcotic drugs and psychotropic substances
Available: http://www.unodc.org/pdf/convention_1988_en.pdf. Accessed 11 August 2007.
35. ChenDZQingHRYangC
2004
Multistage hydrothermal dolomites in the Middle Devonian (Givetian) carbonates from the Guilin area, South China.
Sedimentology
51
1029
1051
36. International Agency for Research on Cancer
2007
Overall evaluations of carcinogenicity to humans
Available: http://monographs.iarc.fr/ENG/Classification/crthalllist.php. Accessed 11 August 2007.
37. MildenhallDC
1990
Forensic palynology in New Zealand.
Rev Palaeobot Palynol
64
227
234
38. MilneLABryantVMMildenhallDC
2004
Forensic palynology.
In:
CoyleHM
Forensic botany
Boca Raton, USA
CRC Press
217
252
39. BryantVMJonesJGMildenhallDC
1996
Forensic studies in palynology.
In:
JansoniusJMcGregorDC
Palynology: principles and applications
Am Assoc Strat Palynol Found
3
957
959
40. StanleyEA
1992
Application of palynology to establish the provenance and travel history of illicit drugs.
Microscope
40
149
152
41. LiuXWangJYWangQF
2005
Current status and conservation strategies for Isoetes in China: a case study for the conservation of threatened aquatic plants.
Oryx
39
335
338
42. Anon.
GlaxoSmithKline case study (7 April 2003). Judicial Protection of IPR in China
Available: http://www.chinaiprlaw.com/english/news/news14.htm. Accessed 5 August 2007.
43. AminAAKokwaroGO
2007
Antimalarial drug quality in Africa.
J Clin Pharm Ther
32
429
440
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2008 Číslo 2
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Co dělat při intoleranci statinů?
- Pleiotropní účinky statinů na kardiovaskulární systém
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
Najčítanejšie v tomto čísle
- Eliminating Human African Trypanosomiasis: Where Do We Stand and What Comes Next?
- Solving the Mystery of Myelodysplasia
- The Neglected Diseases Section in : Moving Beyond Tropical Infections
- Should Data from Demographic Surveillance Systems Be Made More Widely Available to Researchers?